---
annotations:
- id: PW:0000754
  parent: drug pathway
  type: Pathway Ontology
  value: drug pathway
- id: DOID:3068
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: glioblastoma
- id: CL:0000125
  parent: animal cell
  type: Cell Type Ontology
  value: glial cell
authors:
- Eweitz
- Egonw
- Sikeda
citedin: ''
communities: []
description: '"Therapeutic tyrosine kinase inhibitors and anti-EGFR monoclonal antibodies
  in glioblastoma anti-EGFR mAbs bind the EGFR extracellular domain, preventing EGFR
  dimerization and subsequent activation. Tyrosine kinase inhibitors (TKIs) target
  the intracellular TK domain, blocking subsequent receptor tyrosine kinase pathways
  (RTKs)" From Figure F3 in https://pmc.ncbi.nlm.nih.gov/articles/PMC10967338.  Derived
  from https://pfocr.wikipathways.org/figures/PMC10967338__antibodies-13-00025-g003.html'
last-edited: 2025-06-04
ndex: null
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5494
- /instance/WP5494
- /instance/WP5494_r139336
revision: r139336
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5494.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: '"Therapeutic tyrosine kinase inhibitors and anti-EGFR monoclonal antibodies
    in glioblastoma anti-EGFR mAbs bind the EGFR extracellular domain, preventing
    EGFR dimerization and subsequent activation. Tyrosine kinase inhibitors (TKIs)
    target the intracellular TK domain, blocking subsequent receptor tyrosine kinase
    pathways (RTKs)" From Figure F3 in https://pmc.ncbi.nlm.nih.gov/articles/PMC10967338.  Derived
    from https://pfocr.wikipathways.org/figures/PMC10967338__antibodies-13-00025-g003.html'
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - Afatinib
  - BTC
  - Cetuximab
  - Dacomitinib
  - EGF
  - EREG
  - Erlotinib
  - GRB2
  - Gefitinib
  - HRAS
  - JAK1
  - JAK2
  - JAK3
  - KRAS
  - Lapatinib
  - MAP2K1
  - MAP2K2
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MTOR
  - NRAS
  - Neratinib
  - PDK1
  - PIP2
  - PIP3
  - PTEN
  - Panitumumab
  - RAF1
  - RHEB
  - RPTOR
  - SOS1
  - SOS2
  - STAT3
  - TGFA
  - TSC1
  - TSC2
  - TYK2
  license: CC0
  name: Tyrosine kinase inhibitors in glioblastoma
seo: CreativeWork
title: Tyrosine kinase inhibitors in glioblastoma
wpid: WP5494
---